Clarifying design, safety, and immune correlates in short-course hypofractionated radiotherapy for limited-stage small-cell lung cancer.
APA
Yin Q, Wang Z (2026). Clarifying design, safety, and immune correlates in short-course hypofractionated radiotherapy for limited-stage small-cell lung cancer.. Translational lung cancer research, 15(1), 23. https://doi.org/10.21037/tlcr-2025-aw-1149
MLA
Yin Q, et al.. "Clarifying design, safety, and immune correlates in short-course hypofractionated radiotherapy for limited-stage small-cell lung cancer.." Translational lung cancer research, vol. 15, no. 1, 2026, pp. 23.
PMID
41659254
같은 제1저자의 인용 많은 논문 (5)
- Comment on "Hope and its relationship with treatment/physical related factors in lung cancer patients receiving immunotherapy".
- Navigating the future of gastric cancer treatment: a review on the impact of antibody-drug conjugates.
- Blood transfusion mediated tumor microenvironment remodeling in breast cancer.
- Patterns and risk factors of intracranial recurrence after surgical resection of brain metastases from malignant tumors.
- Targeting calreticulin (CALR) in tumors: Cellular mechanisms, structural insights and ligand development advances.